A chromosomal -lactamase gene from Bacillus clausii NR, which is used as a probiotic, was cloned and expressed in Escherichia coli. It encodes a clavulanic acid-susceptible Ambler class A -lactamase, BCL-1, with a pI of 5.5 and a molecular mass of ca. 32 kDa. It shares 91% and 62% amino acid identity with the chromosomally encoded PenP penicillinases from B. clausii KSM-K16 and Bacillus licheniformis, respectively. The hydrolytic profile of this -lactamase includes penicillins, narrow-spectrum cephalosporins, and cefpirome. This chromosome-encoded enzyme was inducible in B. clausii, and its gene is likely related to upstreamlocated regulatory genes that share significant identity with those reported to be upstream of the penicillinase gene of B. licheniformis. The bla BCL-1 gene was located next to the known chromosomal aadD2 gene and the erm34 gene, which encode resistance to aminoglycosides and macrolides, respectively. Similar genes were found in a collection of B. clausii reference strains.Bacillus species are used as probiotics in both humans and animals for the prevention of infectious bacterial diarrhea (8,10,18,28) or preneoplastic lesions (29). Enterogermina (SanofiAventis, Milan, Italy) is a pharmaceutical preparation containing an aqueous suspension of a mix of viable antibiotic-resistant alkaliphilic Bacillus clausii strains (NR, OC, SIN, and T) (10), initially identified as Bacillus subtilis (37). B. clausii spores are able to germinate after exposure to acidic pH in the stomach and to grow in the presence of bile and with a limited amount of oxygen, consistent with the beneficial health effect of probiotics (8). In their vegetative form, B. clausii strains are able to induce an immune response (39), as recently described for "Bacillus polyfermenticus" (22). Bacillus spores are used as probiotics, although they may carry antibiotic resistance determinants and express toxins (14,19). Resistance to erythromycin is one of the reported features of B. clausii (3, 10), due to the presence of an erm-related gene (5). B. clausii strains are also resistant to penicillin G, cephalothin, and cefotaxime (4).Therefore, it was interesting to determine the resistance determinants responsible for resistance phenotype in B. clausii. The study was initiated with one of the strains, B. clausii NR, present in the Enterogermina mixture and with the B. clausii reference strain ATCC 21537. A -lactamase with an uncommon hydrolytic profile that included cefpirome was characterized.
MATERIALS AND METHODSBacterial strains. B. clausii NR, SIN, T, OC, and DSM 8716 were from Sanofi-Aventis. B. clausii ATCC 21537 was used as a reference strain. Most of the work reported below was performed in parallel with B. clausii NR and ATCC 21537 strains. Escherichia coli DH10B and E. coli BL21(DE3) (Invitrogen, Life Technologies, Cergy-Pontoise, France) were used for cloning experiments and -lactamase overexpression, respectively (17).Antimicrobial agents and MIC determinations. The antimicrobial agents and their sources are described ...